Saroja Pharma Industries India Ltd (SAROJA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Saroja Pharma Industries India Ltd on NSE and BSE, with an AI summary of each filing.
Saroja Pharma Industries India Limited has informed the Exchange regarding Resignation of M/s Pravin Chandak & Associates, Chartered Accountants as Statutory Auditors of the company w.e.f. October 26, 2026.
Change in Management · 26 Oct 2026, 9:22 pm
Saroja Pharma Statutory Auditor Resigns Due to Professional Pre-Occupations Pravin Chandak & Associates resigned as Statutory Auditors of Saroja Pharma Industries India Limited, effective from the close of business hours on 26th Oct'26. The auditor cited pre-occupation with other professional assignments as the reason for inability to devote adequate time. The auditor confirmed completing the audit for the financial year ended 31st Mar'26 without commencing work for FY27, noting no management-related concerns or material issues. The Audit Committee and Board will appoint a replacement auditor to fill the casual vacancy in due course.
Saroja Pharma Industries India Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 06 Oct 2026, 12:35 am
Saroja Pharma Industries India Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 06 Oct 2026, 12:34 am
Saroja Pharma Industries India Limited has informed the Exchange regarding Resignation of Mr. Ravindra Shivaji Salaskar as Whole-time Director of the company w.e.f. October 05, 2026.
Change in Management · 05 Oct 2026, 11:55 pm
Ravindra Shivaji Salaskar Resigns as Whole-Time Director of Saroja Pharma Saroja Pharma Industries India Limited announced that Mr. Ravindra Shivaji Salaskar has resigned from his position as Whole-time Director, effective from the close of business hours on 5th Oct'26, citing personal reasons to realign professional commitments. However, he will continue his association with the company in his existing executive role as Chief Financial Officer (CFO). The company confirmed there are no other material reasons for his stepping down from the Board.
Saroja Pharma Industries India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 02 Oct 2026, 6:43 pm
Saroja Pharma Industries India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Annual General Meeting · 30 Sept 2026, 10:07 pm
Saroja Pharma Industries India Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026.
Outcome · 25 Sept 2026, 7:14 pm
Saroja Pharma Appoints Ravindra Shivaji Salaskar as Chief Financial Officer The Board of Directors of Saroja Pharma Industries India Limited, at its meeting held on 25th Sep'26, approved the appointment of Whole-time Director Mr. Ravindra Shivaji Salaskar as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective immediately. Mr. Salaskar, who holds over 40 years of experience across finance, accounts, compliance, and business operations, will also continue in his role as Whole-time Director for a five-year tenure running through 8th Oct'30. He is not related to any other company director.
Saroja Pharma Industries India Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 08 Sept 2026, 2:34 am
Saroja Pharma Industries India Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026.
Outcome · 08 Sept 2026, 1:42 am
Saroja Pharma Approves FY26 Board Report and 8th AGM Notice Saroja Pharma Industries India Limited's Board of Directors met on 7th Sep'26 and approved the Draft Board's Report and Management Discussion & Analysis (MD&A) Report alongside their annexures for FY25-26, in compliance with the Companies Act, 2013, and SEBI (LODR) Regulations. Additionally, the board approved the draft notice convening the company's 8th Annual General Meeting (AGM) and finalized its scheduled date, time, and venue.
Significant movement in price has been observed in Saroja Pharma Industries India Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Others (Uncategorized) · 28 Aug 2026, 11:34 pm
Saroja Pharma Industries India Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2026.
Outcome · 22 Aug 2026, 9:06 pm
Saroja Pharma Announces Key Management and Auditor Appointments Saroja Pharma's board, in a meeting on 22 Aug'26, re-designated Mr. Pulinattu Damodaran Nandakumar from Non-Executive to Whole-time Director to enhance executive leadership for expanding operations. Mr. Nandakumar, who has over 35 years of industry experience, is the cousin of Managing Director Biju Gopinathan Nair. The board also appointed Mr. Niraj Variava, a Chartered Accountant, as the company’s Internal Auditor for FY 2026-27. Both appointments are effective from 22 Aug'26, with the directorship subject to member approval.